IL2RA and COVID-19: While CD25 expression in healthy individuals was rather low and only moderately detectable in a distinct cell population, the levels were strongly increased in severe COVID-19 patients, being significantly upregulated in CD4+ T cells [Figure 5A; Supplementary Figure S1, (55)].